Browse by Audience
MEMBER

Update Your Profile
Special Interest Groups (SIG)
Member Spotlights
IASP Connect
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Pain Researcher
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Curricula
Graduate Opportunities
Treatment and Education Resources
Events

PATIENT & CAREGIVER

Resources for Living with Pain
Topic Pages
Free Videos
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner
Make a Donation

I am a
IASP Logo
Home I AM A Search Login

Papers of the Week

Home / Publications / Pain Research Forum / Papers of the Week / Maralixibat Treatment Response in Alagille Syndrome Is Associated with Improved Health-Related Quality of Life.

< BACK TO ARCHIVE


2022 Sep 09


J Pediatr


http://www.ncbi.nlm.nih.gov/pubmed/36096175?dopt=Abstract

Maralixibat Treatment Response in Alagille Syndrome Is Associated with Improved Health-Related Quality of Life.

Authors

Maralixibat Treatment Response in Alagille Syndrome Is Associated with Improved Health-Related Quality of Life.
Kamath BM, Goldstein A, Howard R, Garner W, Vig P, Marden JR, Billmyer E, Anderson A, Kirson N, Jacquemin E, Gonzales E
J Pediatr. 2022 Sep 09.
PMID: 36096175.

Abstract

(s): To assess the impact of treatment response to the ileal bile acid transporter inhibitor maralixibat on health-related quality of life (HRQoL) in children with Alagille syndrome ( ALGS).
Read This Paper